These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27257236)

  • 21. CRISPR-Based Gene Drives for Pest Control.
    McFarlane GR; Whitelaw CBA; Lillico SG
    Trends Biotechnol; 2018 Feb; 36(2):130-133. PubMed ID: 29221716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlling and enhancing CRISPR systems.
    Shivram H; Cress BF; Knott GJ; Doudna JA
    Nat Chem Biol; 2021 Jan; 17(1):10-19. PubMed ID: 33328654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced scale and scope of genome engineering and regulation using CRISPR/Cas in Saccharomyces cerevisiae.
    Deaner M; Alper HS
    FEMS Yeast Res; 2019 Nov; 19(7):. PubMed ID: 31665284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR snapshots of a gene-editing tool.
    Krasteva PV
    Nat Methods; 2014 Apr; 11(4):365. PubMed ID: 24818224
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
    Yang H; Patel DJ
    Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-organism lineage tracing by combinatorial and cumulative genome editing.
    McKenna A; Findlay GM; Gagnon JA; Horwitz MS; Schier AF; Shendure J
    Science; 2016 Jul; 353(6298):aaf7907. PubMed ID: 27229144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted candidate gene screens using CRISPR/Cas9 technology.
    Shah AN; Moens CB; Miller AC
    Methods Cell Biol; 2016; 135():89-106. PubMed ID: 27443921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
    Grenier F; Lucier JF; Rodrigue S
    Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A G-quadruplex motif at the 3' end of sgRNAs improves CRISPR-Cas9 based genome editing efficiency.
    Nahar S; Sehgal P; Azhar M; Rai M; Singh A; Sivasubbu S; Chakraborty D; Maiti S
    Chem Commun (Camb); 2018 Mar; 54(19):2377-2380. PubMed ID: 29450416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR Guide RNA Validation In Vitro.
    Grainger S; Lonquich B; Oon CH; Nguyen N; Willert K; Traver D
    Zebrafish; 2017 Aug; 14(4):383-386. PubMed ID: 27829120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
    Liu Q; Zhang H; Huang X
    FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo.
    Moreno-Mateos MA; Vejnar CE; Beaudoin JD; Fernandez JP; Mis EK; Khokha MK; Giraldez AJ
    Nat Methods; 2015 Oct; 12(10):982-8. PubMed ID: 26322839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OffScan: a universal and fast CRISPR off-target sites detection tool.
    Cui Y; Liao X; Peng S; Tang T; Huang C; Yang C
    BMC Genomics; 2020 Mar; 21(Suppl 1):872. PubMed ID: 32138651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR-Cas systems: ushering in the new genome editing era.
    Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
    Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleic Acid-Dependent Conformational Changes in CRISPR-Cas9 Revealed by Site-Directed Spin Labeling.
    Vazquez Reyes C; Tangprasertchai NS; Yogesha SD; Nguyen RH; Zhang X; Rajan R; Qin PZ
    Cell Biochem Biophys; 2017 Jun; 75(2):203-210. PubMed ID: 27342128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a.
    Swartjes T; Staals RHJ; van der Oost J
    Biochem Soc Trans; 2020 Feb; 48(1):207-219. PubMed ID: 31872209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in the CRISPR genome editing tool set.
    Moon SB; Kim DY; Ko JH; Kim YS
    Exp Mol Med; 2019 Nov; 51(11):1-11. PubMed ID: 31685795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.